Review article · 2016 · Open access
Targeting Inflammation in Cancer Prevention and Therapy
Cancer Prevention Research, 9(12), 895–905 · Published 11 November 2016 · DOI 10.1158/1940-6207.capr-16-0209
In brief
“Targeting Inflammation in Cancer Prevention and Therapy” is a 2016 review article by Jelena Todoric and 2 co-authors, published in Cancer Prevention Research. OpenAlex counts 382 citations as of 15 November 2026. It is open access: the full text is free to read at PubMed Central.
- Citations
- 382
- Most cited in
- 2020 (57)
- Field-weighted impact
- 3.66
- References
- 150
- Authors
- 3
Abstract
Inflammation is associated with the development and malignant progression of most cancers. As most of the cell types involved in cancer-associated inflammation are genetically stable and thus are not subjected to rapid emergence of drug resistance, the targeting of inflammation represents an attractive strategy both for cancer prevention and for cancer therapy. Tumor-extrinsic inflammation is caused by many factors, including bacterial and viral infections, autoimmune diseases, obesity, tobacco smoking, asbestos exposure, and excessive alcohol consumption, all of which increase cancer risk and stimulate malignant progression. In contrast, cancer-intrinsic or cancer-elicited inflammation can be triggered by cancer-initiating mutations and can contribute to malignant progression through the recruitment and activation of inflammatory cells. Both extrinsic and intrinsic inflammation can result in immunosuppression, thereby providing a preferred background for tumor development. In clinical trials, lifestyle modifications including healthy diet, exercise, alcohol, and smoking cessation have proven effective in ameliorating inflammation and reducing the risk of cancer-related deaths. In addition, consumption of certain anti-inflammatory drugs, including aspirin, can significantly reduce cancer risk, suggesting that common nonsteroidal anti-inflammatory drugs (NSAID) and more specific COX2 inhibitors can be used in cancer prevention. In addition to being examined for their preventative potential, both NSAIDs and more potent anti-inflammatory antibody-based drugs need to be tested for their ability to augment the efficacy of more conventional therapeutic approaches on the basis of tumor resection, radiation, and cytotoxic chemicals. Cancer Prev Res; 9(12); 895-905. ©2016 AACR.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Todoric, J., Antonucci, L., & Karin, M. (2016). Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prevention Research, 9(12), 895–905. https://doi.org/10.1158/1940-6207.capr-16-0209
MLA 9
Todoric, Jelena, et al. “Targeting Inflammation in Cancer Prevention and Therapy.” Cancer Prevention Research, vol. 9, no. 12, 2016, pp. 895–905. https://doi.org/10.1158/1940-6207.capr-16-0209.
Chicago
Todoric, Jelena, Laura Antonucci, and Michael Karin. 2016. “Targeting Inflammation in Cancer Prevention and Therapy.” Cancer Prevention Research 9 (12): 895–905. https://doi.org/10.1158/1940-6207.capr-16-0209.
Harvard
Todoric, J., Antonucci, L. and Karin, M. (2016) ‘Targeting Inflammation in Cancer Prevention and Therapy’, Cancer Prevention Research, 9(12), pp. 895–905. doi:10.1158/1940-6207.capr-16-0209.
IEEE
J. Todoric, L. Antonucci, and M. Karin, “Targeting Inflammation in Cancer Prevention and Therapy,” Cancer Prevention Research, vol. 9, no. 12, pp. 895–905, 2016, doi: 10.1158/1940-6207.capr-16-0209.
BibTeX
@article{todoric2016targeting,
title = {{Targeting Inflammation in Cancer Prevention and Therapy}},
author = {Todoric, Jelena and Antonucci, Laura and Karin, Michael},
journal = {Cancer Prevention Research},
year = {2016},
volume = {9},
number = {12},
pages = {895--905},
doi = {10.1158/1940-6207.capr-16-0209},
url = {https://doi.org/10.1158/1940-6207.capr-16-0209}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 28 | |
| 2018 | 29 | |
| 2019 | 43 | |
| 2020 | 57 | |
| 2021 | 49 | |
| 2022 | 47 | |
| 2023 | 41 | |
| 2024 | 46 | |
| 2025 | 25 | |
| 2026 | 16 |
Its field-weighted citation impact is 3.66: it has been cited 3.66 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- inflammation
- tumor inflammation
- cancer prevention
- cancer therapy
- tumor microenvironment
- tumor immunosuppression
- lifestyle modification
- nonsteroidal anti-inflammatory drugs
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Todoric, J., Antonucci, L., & Karin, M. (2016). Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prevention Research, 9(12), 895–905. https://doi.org/10.1158/1940-6207.capr-16-0209
How many times has this paper been cited?
382 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at PubMed Central.
Who wrote this paper?
Jelena Todoric, Laura Antonucci, Michael Karin.
What is the DOI of this paper?
10.1158/1940-6207.capr-16-0209. The permanent link is https://doi.org/10.1158/1940-6207.capr-16-0209.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.